Skip to content

13F-HR filed by Altium Capital Management LLC

Altium Capital Management LLC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 134 holding rows worth $272,757,000.

Accession
0001420506-22-002182
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A holdings report, 134 entries on the cover page, a total value of $272,757,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $272,757,000 with VALUE read as thousands by filing date, 13F file number 028-20820. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BELLUS HEALTH INC NEW07987C204COM1,132,000$11,954,000thousands by filing date
CHINOOK THERAPEUTICS INC16961L106COM525,000$10,322,000thousands by filing date
CHEMOCENTRYX INC16383L106COM160,000$8,266,000thousands by filing date
PEPPERLIME HEALTH ACQUSTN COG70021103COM735,000$7,343,000thousands by filing date
ADMA BIOLOGICS INC000899104COM2,883,710$7,007,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM1,750,000$6,125,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock268,000$5,773,000thousands by filing date
GUARDANT HEALTH INC40131M909COM100,000$5,383,000thousands by filing datecall
NOCTURNE ACQUISITION CORPG6580S114ORDINARY SHARES500,000$5,165,000thousands by filing date
GLAUKOS CORP COM377322102Stock97,000$5,164,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM140,000$4,767,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK100,000$4,653,000thousands by filing date
XTANT MED HLDGS INC98420P308COM NEW6,246,291$4,496,000thousands by filing date
PLIANT THERAPEUTICS INC729139105COM215,000$4,491,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock659,869$4,421,000thousands by filing date
BIOATLA INC09077B104COM553,000$4,258,000thousands by filing date
ILLUMINA INC452327109COM22,000$4,197,000thousands by filing date
RHYTHM PHARMACEUTICALS INC76243J105COM170,000$4,165,000thousands by filing date
VERONA PHARMA PLC925050106SPONSORED ADS404,000$4,129,000thousands by filing date
KARYOPHARM THERAPEUTICS INC48576U106COM750,000$4,095,000thousands by filing date
ASTRIA THERAPEUTICS INC COM04635X102Stock445,000$4,023,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W106CMN400,000$4,008,000thousands by filing date
ANGIODYNAMICS INC03475V101COM195,000$3,990,000thousands by filing date
NULL09071M205NULL4,149,262$3,838,000thousands by filing date
KARUNA THERAPEUTICS INC48576A100COM17,000$3,824,000thousands by filing date
RESMED INC COM761152107Stock17,000$3,711,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM280,000$3,576,000thousands by filing date
QUIDELORTHO CORP COM219798105Stock50,000$3,574,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock66,000$3,553,000thousands by filing date
MYRIAD GENETICS INC62855J104COM186,000$3,549,000thousands by filing date
INOGEN INC45780L104COM146,000$3,545,000thousands by filing date
AKOYA BIOSCIENCES INC COM00974H104Stock296,000$3,478,000thousands by filing date
PROCEPT BIOROBOTICS CORP COM74276L105Stock81,000$3,358,000thousands by filing date
EIGER BIOPHARMACEUTICALS INC28249U105COM440,000$3,313,000thousands by filing date
KEROS THERAPEUTICS INC COM492327101Stock88,000$3,311,000thousands by filing date
NATERA INC COM632307104Stock75,000$3,287,000thousands by filing date
ALPHATEC HLDGS INC02081G201COM NEW342,000$2,989,000thousands by filing date
NEVRO CORP64157F103COM64,000$2,982,000thousands by filing date
LANTHEUS HLDGS INC516544103COM42,000$2,954,000thousands by filing date
SI BONE INC825704109COM167,000$2,916,000thousands by filing date
VERASTEM INC92337C104COM3,000,000$2,550,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T108CMN254,000$2,540,000thousands by filing date
CTI BIOPHARMA CORP12648L601COM427,000$2,485,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock150,000$2,450,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM68,000$2,396,000thousands by filing date
SARISSA CAPITAL ACQUISITN COG7823W102CMN225,000$2,250,000thousands by filing date
IVERIC BIO INC46583P102COM125,000$2,243,000thousands by filing date
KORU MEDICAL SYSTEMS INC759910102COMMON STOCK995,500$2,220,000thousands by filing date
ARCELLX INC COMMON STOCK03940C100Stock115,000$2,159,000thousands by filing date
OCULAR THERAPEUTIX INC67576A100COM517,133$2,146,000thousands by filing date
ADICET BIO INC007002108COM150,000$2,133,000thousands by filing date
INSPIRE MED SYS INC COM457730109Stock12,000$2,128,000thousands by filing date
2SEVENTY BIO INC COMMON STOCK901384107Stock140,000$2,037,000thousands by filing date
TG VENTURE ACQUISITION CORP87251T208UNIT 08/15/2028200,000$2,020,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM19,000$2,018,000thousands by filing date
LAKESHORE ACQUISITION II CORG5352N105ORDINARY SHARES200,000$2,016,000thousands by filing date
JIYA ACQUISITION CORP47760M102CMN200,000$1,994,000thousands by filing date
UNIQURE NVN90064101SHS105,000$1,970,000thousands by filing date
COLLEGIUM PHARMACEUTICAL INC19459J104COM116,000$1,858,000thousands by filing date
VERICEL CORP92346J108COM80,000$1,856,000thousands by filing date
AFFIMED N VN01045108COM900,000$1,854,000thousands by filing date
CARA THERAPEUTICS INC140755109COM193,000$1,806,000thousands by filing date
EYEPOINT INC COM NEW30233G209Stock224,541$1,776,000thousands by filing date
MEDIWOUND LTDM68830104ORD SHS1,276,948$1,775,000thousands by filing date
UNITY BIOTECHNOLOGY INC91381U101COM4,270,000$1,687,000thousands by filing date
HILLMAN SOLUTIONS CORP431636109COM221,000$1,666,000thousands by filing date
TREVI THERAPEUTICS INC COM89532M101Stock1,066,157$1,642,000thousands by filing date
GOSSAMER BIO INC COM38341P102Stock135,000$1,617,000thousands by filing date
CASTLE BIOSCIENCES INC14843C105COMMON STOCK60,000$1,565,000thousands by filing date
ALKERMES PLCG01767105SHS70,000$1,563,000thousands by filing date
DIGITAL HEALTH ACQUISITION C253893200UNIT 11/02/2026150,000$1,545,000thousands by filing date
AULT DISRUPTIVE TECHS CORP05150A104COM150,000$1,512,000thousands by filing date
FAT BRANDS INC30258N121*W EXP 07/16/202227,000$1,171,000thousands by filing date
QUANTERIX CORP74766Q101COMMON STOCK95,000$1,047,000thousands by filing date
LARIMAR THERAPEUTICS INC517125100COM320,000$1,024,000thousands by filing date
INDUSTRIAL HUMAN CAPITAL INC45617P104CMN100,000$1,015,000thousands by filing date
WESTERN ACQSTN VENTURES CORP95758L206UNIT 09/01/2026100,000$1,010,000thousands by filing date
RELATIVITY ACQUISITION CORP75944B205UNIT 02/10/2027100,000$1,008,000thousands by filing date
MURPHY CANYON ACQUISITION CO626642201UNIT 01/25/2027100,000$1,004,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN100,000$1,002,000thousands by filing date
OPY ACQUISITION CORP I671005106COM100,000$993,000thousands by filing date
OMEGA ALPHA SPACG6749V107CL A100,000$993,000thousands by filing date
ARYA SCIENCES ACQU CORP IVG31659108COM100,000$991,000thousands by filing date
AMYLYX PHARMACEUTICALS INC03237H101COM35,000$985,000thousands by filing date
RENOVACOR INC75989E106COM388,845$980,000thousands by filing date
AEROVATE THERAPEUTICS INC008064107COM51,000$846,000thousands by filing date
COLISEUM ACQUISITION CORPG2263T123COM85,000$835,000thousands by filing date
CLENE INC185634952COMMON STOCK281,500$788,000thousands by filing dateput
POLISHED COM INC28252C117*W EXP 06/02/2026,103,824$763,000thousands by filing date
RELMADA THERAPEUTICS INC75955J952COM18,200$674,000thousands by filing dateput
SADOT GROUP INC627333107COM1,771,331$666,000thousands by filing date
DOUBLEDOWN INTERACTIVE CO LT25862B109ADS60,876$562,000thousands by filing date
PALISADE BIO INC696389105COM5,643,007$559,000thousands by filing date
GSR II METEORA ACQUISITN COR36263W204UNIT 02/24/202750,000$514,000thousands by filing date
COLOMBIER ACQUISITION CORP19533H108COM50,000$488,000thousands by filing date
PEPGEN INC COM713317105Stock40,000$363,000thousands by filing date
TTOO89853L104Stock2,840,000$321,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK8,500$315,000thousands by filing date
WEARABLE DEVICES LTDM97838110*W EXP 09/14/2021,411,600$295,000thousands by filing date
AMYLYX PHARMACEUTICALS INC03237H951COM9,000$253,000thousands by filing dateput
Benitec Biopharma, Inc.08205P100common658,796$245,000thousands by filing date
TWIN VEE POWERCATS CO90177C101COM67,798$165,000thousands by filing date
VIGIL NEUROSCIENCE INC92673K108COM15,788$144,000thousands by filing date
NOVABAY PHARMACEUTICALS INC66987P201COM NEW1,095,957$121,000thousands by filing date
LIGHTNING EMOTORS INC 11.5000EXP05/18/202553228T119WARR652,173$120,000thousands by filing date
TC BIOPHARM HOLDINGS PLC87807D111*W EXP 02/10/202941,176$118,000thousands by filing date
HARBOR CUSTOM DEVELOPMENT IN41150T124*W EXP 10/07/202650,000$114,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS10,000$99,000thousands by filing date
HARBOR CUSTOM DEVELOPMENT IN41150T116*W EXP 05/09/202600,000$91,000thousands by filing date
NEXGEL INC65344E115*W EXP 12/27/202225,000$68,000thousands by filing date
INNOVATIVE EYEWEAR INC45791D117*W EXP 08/16/202150,000$60,000thousands by filing date
Cingulate Inc W Exp 12/10/20217248W113Warrant270,000$59,000thousands by filing date
Renovacor Inc75989E114Warrant731,561$58,000thousands by filing date
BRUUSH ORAL CARE INC11750K120*W EXP 08/03/202120,193$52,000thousands by filing date
DIRECT DIGITAL HOLDINGS INC25461T113*W EXP 02/15/202180,000$49,000thousands by filing date
NLS PHARMACEUTICS LTDH57830111*W EXP 02/02/202200,000$43,000thousands by filing date
NEXERA TECHNOLOGIES LTDM61472110*W EXP 08/26/202240,385$40,000thousands by filing date
CEA INDUSTRIES INC86887P119*W EXP 02/11/202250,000$38,000thousands by filing date
ONFOLIO HOLDINGS INC68277K124*W EXP 01/02/202200,000$30,000thousands by filing date
LAKESHORE ACQUISITION I CORPG53521111*W EXP 07/15/202150,000$30,000thousands by filing date
PEPPERLIME HEALTH ACQUSTN COG70021111*W EXP 10/01/202367,500$27,000thousands by filing date
NOCTURNE ACQUISITION CORPG6580S106RIGHT 12/26/2025500,000$22,000thousands by filing date
NEXALIN TECHNOLOGY INC65345B110*W EXP 99/99/999105,000$19,000thousands by filing date
SURROZEN INC86889P117*W EXP 08/01/20382,233$15,000thousands by filing date
CHAVANT CAPITAL ACQUISITN COG2058L111*W EXP 99/99/999150,000$7,000thousands by filing date
OPY ACQUISITION CORP I671005114*W EXP 09/22/20250,000$5,000thousands by filing date
EUCRATES BIOMEDICAL ACQU CORG3141W122*W EXP 10/23/202133,333$5,000thousands by filing date
WTS AULT DISRUPTIVE TECHNOLOGI05150a112WT112,500$5,000thousands by filing date
GIGINTERNATIONAL1 INC37518W114*W EXP 04/19/20250,000$3,000thousands by filing date
COLISEUM ACQUISITION CORPG2263T107*W EXP 08/22/20228,333$2,000thousands by filing date
COLOMBIER ACQUISITION CORP19533H116*W EXP 99/99/99916,666$2,000thousands by filing date
INDUSTRIAL HUMAN CAPITAL INC45617P112WTS100,000$2,000thousands by filing date
TURMERIC ACQUISITION CORPG9127T124WTS84,666$2,000thousands by filing date
SARISSA CAPITAL ACQUISITN COG7823W110*W EXP 10/23/20275,000$2,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-002182this filing2022-11-14acceptance time not in the bulk data set